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SUMMARY
Heart failure is a leading cause of mortality and
morbidity in the developed world, partly because
mammals lack the ability to regenerate heart tissue.
Whether this is due to evolutionary loss of regenera-
tive mechanisms present in other organisms or to an
inability to activate such mechanisms is currently un-
clear. Herewedeciphermechanisms underlying heart
regeneration in adult zebrafish and show that the mo-
lecular regulators of this response are conserved in
mammals. We identified miR-99/100 and Let-7a/c
and their protein targets smarca5 and fntb as critical
regulators of cardiomyocyte dedifferentiation and
heart regeneration in zebrafish. Although human and
murine adult cardiomyocytes fail to elicit an endo-
genous regenerative response after myocardial in-
farction, we show that in vivo manipulation of this
molecularmachinery inmice results in cardiomyocyte
dedifferentiation and improved heart functionality
after injury. These data provide a proof of concept
for identifying and activating conserved molecular
programs to regenerate the damaged heart.
INTRODUCTION
Cardiovascular diseases remain the major contributors to the
high mortality and morbidity rates in developed countries. Heart
failure due to poor ventricle myocardial contractile performance
has become a worldwide public health problem. Noticeably,
adult mammalian hearts have been shown to elicit a primitive
regenerative response upon injury (Addis and Epstein, 2013;
Aguirre et al., 2013; Laflamme and Murry, 2011). Supporting
this notion, mature differentiated mammalian cardiomyocytes
have been shown to re-enter the cell cycle upon application of
chemical compounds targeting specific signaling pathways
(Bersell et al., 2009). However, in all cases, the regenerative
response is insufficient for the healing and complete recovery
of myocardial function. Interestingly, lower vertebrates such as
the zebrafish are able to naturally activate endogenous regener-
ative responses that lead to complete heart regeneration
throughout their entire lifetime by a process of cardiomyocyte
dedifferentiation (Jopling et al., 2010; Kikuchi et al., 2010; Poss
et al., 2002; Raya et al., 2003). Dedifferentiated cardiomyocytes
were shown to re-enter the cell cycle and accounted for all newly
formed cells repairing the heart (Jopling et al., 2010; Kikuchi
et al., 2010). Different hypotheses have been considered to
explain these different responses across species (Brockes and
Kumar, 2008; Poss, 2010). One possibility is that regenerative
mechanisms have been positively or negatively selected during
evolution and are therefore absent in the mammalian genome.
Alternatively, regenerative mechanisms, following injury, even
though present, might remain silenced due to differences in
epigenetic regulatory mechanisms when compared with species
able to regenerate (Brockes and Kumar, 2008; Kragl et al., 2009;
Lehoczky et al., 2011; Seifert et al., 2012; Stewart et al., 2009).
Certain regenerative processes present in neonate mammals
and redolent of development have been described (Porrello
et al., 2011; Xin et al., 2013a). Moreover, a recent finding has
reported regeneration in several tissues upon metabolic reprog-
ramming and manipulation of Lin28. However, despite success-
ful in several tissues, adult murine heart regeneration could not
be accomplished by this approach (Shyh-Chang et al., 2013a).
Therefore, the mechanisms underlying heart regeneration and
whether they can be activated in adult individuals remain
obscure (Aguirre et al., 2013; Xin et al., 2013b).
Here we investigate the regenerative mechanisms controlling
adult zebrafish heart regeneration and cardiomyocyte dediffer-
entiation and demonstrate that similar mechanisms are indeed
present, yet dormant, in adult mammals. As a response to injury,
we identify miR-99/100 and Let-7a/c downregulation and the
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subsequent upregulation of two of their target genes, fntb and
smarca5 as critical steps required for heart regeneration in the
adult zebrafish. This process fails to be activated in adult
mammals upon injury. Experimental modulation in mice of any
of the identified molecules in zebrafish, whether by anti-miR de-
livery or overexpression of their downstream targets FNTb and
SMARCA5, results in adult cardiomyocyte dedifferentiation, the
activation of a proliferative response, and ultimately, facilitates
mammalian heart regeneration in vivo.
RESULTS
Mechanisms Controlling Zebrafish Heart Regeneration
Are Conserved in the Mammalian Genome
We and others have previously described that adult zebrafish
heart regeneration occurs at the cellular level by dedifferentiation
of mature cardiomyocytes followed by proliferation and further
redifferentiation (Jopling et al., 2010; Kikuchi et al., 2010). More
recently, it has been shown that epigenetic remodeling is a key
step controlling regenerative processes (Kragl et al., 2009;
Zhang et al., 2013). To further investigate the pathways underly-
ing heart regeneration, we decided to focus on microRNAs
(given their wide potential to regulate gene expression changes)
differentially regulated during zebrafish heart regeneration (Eula-
lio et al., 2012; Ivey and Srivastava, 2010). Three days postam-
putation (dpa) of the ventricular apex, we observed significant
changes in the expression of 60 microRNAs (Figure S1A avail-
able online). We focused our attention on those microRNAs pre-
senting significant expression changes that were additionally
conserved to a high degree across vertebrates, both in micro-
RNA sequence and 30 UTR binding sites. This approach identi-
fied two microRNA families (miR-99/100, let-7a/c), which were
clustered in two well-defined genomic locations (miR-99/Let-
7c andmiR-100/Let-7a; Figure S1B) and strongly downregulated
during regeneration (Figures 1A and S1A). Bioinformatic analysis
for gene ontology (GO) processes controlled by these twomicro-
RNA clusters indicated significant enrichment in proliferation
pathways, as well as processes related to chromatin remodeling
and morphogenesis (Han et al., 2011; Paige et al., 2012) (Fig-
ure S1C and Table S1). Interestingly, Let-7a/c upregulation has
been previously reported as an important regulator of stem cell
differentiation, and Lin28-mediated Let-7a/c downregulation
has been linked to regenerative processes (Shyh-Chang et al.,
2013a, 2013b). A recent report also indicates a common role
for the miR-99a/let-7c cluster in regulating cardiomyogenesis
(Coppola et al., 2014). Together, Let-7a/c represents an inter-
esting candidate for controlling heart regeneration in combina-
tion with miR-99/100. Next, we sought to identify downstream
targets for miR-99/100. MIRANDA-based microRNA-UTR bind-
ing predictions suggested downstream targets, and a strong
interaction was found for microRNA-99/100 with zebrafish fntb
(beta subunit of farnesyl-transferase) and smarca5 (SWI/SNF-re-
lated matrix associated actin-dependent regulator of chromatin
subfamily a, member 5) (Figure S1D). Confirming our predictions,
gene expression analysis of fntb and smarca5 highlighted a
significant upregulation of both genes, paralleling the downregu-
lation of miR-99/100 and Let-7a/c during zebrafish heart regen-
eration (Figures 1A and 1B). ClustalX alignment of the 30 UTRs on
the three species showed that the interactions sites were highly
evolutionarily conserved in all of them (data not shown). Bio-
informatic predictions allow for the prescreening of potential
miRNA target sequences; however, they do not unequivocally
identify target genes, and potential targets need to be validated
by further biochemical approaches. As reported in other species,
luciferase reporter assays confirmed microRNA binding predic-
tions to both the human and zebrafish fntb and smarca5 30
UTRs (Mueller et al., 2012; Brenner et al., 2012; Chen et al.,
2013; Liang et al., 2014; Sun et al., 2011) (Figure S1E). Together,
these results demonstrate that both fntb and smarca5 mRNAs
are direct targets of miR-99/100.
Regenerative Pathways Are Involved in Zebrafish and
Mammalian Heart Development but Fail to be Activated
in the Injured Mammalian Heart
To shed new light onto the biological role of miR-99/100, we
investigated their potential functional implication in heart devel-
opment as well as during heart regeneration. Because of its
involvement in controlling stem cell differentiation and regenera-
tion as well as its connections to miR-99/100 (Shyh-Chang et al.,
2013a; Coppola et al., 2014), we also studied the role of Let-7a/c.
Quantitative RT-PCR (qRT-PCR) and immunofluorescence ana-
lyses demonstrated low levels of miR-99/100 expression during
early zebrafish heart development concomitantly with high levels
of Smarca5 and Fntb (Figures 1C–1F). Next, we sought to estab-
lish amechanistic link between the identified microRNAs and the
predicted target proteins, Fntb and Smarca5. To do this, we per-
formed injection of antago-miRs blocking miR-99/100 and Let-7
in adult uninjured zebrafish. As shown in Figure S1F, injection of
Figure 1. miR-99/100 and Its Direct Targets Contribute to Zebrafish Heart Regeneration and Development
(A andB) Real-time RT-PCR for microRNA candidatesmiR-99/100 and Let-7a/c (A) and downstream targets fntb and smarca5 (B) in regenerating zebrafish hearts
3 and 7 dpa (n = 8).
(C) Real-time RT-PCR revealed that expression of miR-99/100 is very low during the first stages of development and dramatically increased at 3 dpf in zebrafish
(n = 10).
(D) fntb and smarca5 expression inversely correlates with miR-99/100 in developing embryos (n = 10). Note that in (C) and (D) analyses were done in whole
embryos at 1, 3, and 5 dpf, and whole heart at the adult stage.
(E and F) Representative pictures demonstrating that both Fntb and Smarca5 are present at high levels in the ventricles of developing hearts at 2 and 5 dpf (n = 10).
V, ventricle; A, atrium; Eb, erythroblasts.
(G–I) Knockdown of fntb and/or smarca5 in zebrafish embryos resulted in abnormally small animals (G) and reduced ventricle size in cmlc2:GFP animals (H and I).
The same phenotypes were observed upon injection of miR-99/100 mimics (G–I) (n > 50).
(J) Rescue experiments for the conditions tested in (G) were performed by c-injecting in vitro transcribed mRNAs with modified 50UTRs with corresponding MOs
to determine the specificity of the observed phenotypes (n = 30).
(K) Quantification of the ventricle size for the rescue experiments. Data are represented as mean ± SEM. *p < 0.05.
See also Figure S1 and Table S1.
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Figure 2. miR-99/100 and Its DownstreamTargets Are Differentially Regulated in Dedifferentiated Cardiomyocytes during Heart Regeneration
(A and B) FISH/immunofluorescence were used to determine cardiomyocyte specific expression (MyHC) of miR-99/100, Fntb, and Smarca5 in uninjured and
regenerating zebrafish hearts (3 and 7 dpa). Cardiomyocytes in regenerating hearts exhibited low levels ofmiR-99/100 and inversely correlating high levels of Fntb
and Smarca5 (n = 8).
(legend continued on next page)
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the antago miRs resulted in the concomitant overexpression of
fntb and smarca5 (Figure S1F). Furthermore, functional analyses
by injection ofmiR-99/100mimics aswell as fntb and/or smarca5
translation-blocking morpholinos (MOs) in one-cell stage
cmlc2:GFP transgenic fish embryos resulted in a significantly
reduced ventricle size in spite of the presence of all, apparently
normal, heart structures (ventricle, atrium, valve) as compared
with animals injected with scrambled control MOs (Figures 1G–
1I), indicating a developmental role during heart growth. To
confirm the specificity of the MOs and to rule out global gastru-
lation defects, we next attempted rescue experiments where the
corresponding MOs were coinjected with in vitro-transcribed
mRNAs encoding for the human SMARCA5 and FNTB se-
quences but lacking their endogenous 30 and 50 UTR regions.
Thus, making them insensitive to miRs or MOs. Coinjection of
MOs alongside FNTB and SMARCA5 mRNAs rescued the phe-
notypes observed when MOs were injected alone (Figures 1J
and 1K). Together, these results confirmed the specificity of
the MOs used in these studies as well as demonstrate a causal
link in controlling SMARCA5 and FNTb expression either by sta-
bilizing their respective mRNAs or upon modulation of other fac-
tors controlling their transcription. Next, we monitored miR-99/
100 as well as Fntb and Smarca5 expression in the regenerating
zebrafish heart. Confirming our initial observations, miR-99/100
expression was high and confined to cardiomyocytes in unin-
jured hearts and became almost undetectable upon injury
(Figures 2A, 2B, S2A, and S2B). As expected, miR-99/100 down-
regulation was paralleled by upregulation of their protein tar-
gets Fntb and Smarca5 (Figures 2A, 2B, S2A, and S2B). Immu-
nofluorescence analyses further correlated Fntb and Smarca5
expression with increased histone 3 phosphorylation (H3P) and
proliferating cell nuclear antigen (PCNA) re-expression, both
indicative of cellular proliferation and cardiomyocyte dedifferen-
tiation (Jopling et al., 2010; Kikuchi et al., 2010) (Figures 2C–2F).
Let-7a/c expression was also maximal in adult uninjured zebra-
fish hearts (Figure S2C). Following amputation, we observed Let-
7a/c downregulation (Figures 1A and S2C) accompanied by the
upregulation of its previously described target genes, ras and
c-myc (Figures S2D–S2G). miR-99/100 and Let-7a/c expression,
as well as that of their respective protein targets, returned to
basal levels 30 dpa once regeneration of the ventricle was nearly
completed (Figures S3A and S3B). Next, we designed a series of
in vivo experiments to functionally dissect the role of miR-99/100
in the adult regenerating zebrafish heart. Notably, we first in-
jected miR-99/100 mimics and evaluated fntb and smarca5
expression during regeneration. As expected, avoiding downre-
gulation of miR99-100 during regeneration significantly impaired
fntb and smarca5 expression (Figure S3C), confirming further
that the miR-99/100 cluster does influence the activity of its
targets in vivo. Intracardiac injection of miR-99/100 mimics effi-
ciently blocked the regenerative response in all amputated ani-
mals (Figures 3A and 3B). Reduced bromodeoxyuridine (BrdU)
incorporation indicated that cardiomyocyte proliferation was
significantly disrupted in mimic-treated animals (Figures 3A
and 3C). Inversely, microRNA inhibition in uninjured adult ani-
mals led to significantly enlarged zebrafish hearts, suggesting
a regenerative proliferative response even in the absence of
injury and therefore a direct role for miR-99/100 in controlling
heart mass (Figures 3D–3F). Most interestingly, chemical inhibi-
tion of Fnt with the specific antagonist tipifarnib significantly
impaired heart regeneration by decreasing the number of prolif-
erating cardiomyocytes, further suggesting an active role for
miR-99/100 targets during regeneration (Figures 3G–3I). Taken
together, these results demonstrate a functional role for miR-
99/100, Fntb, and Smarca5 in zebrafish heart development and
adult heart regeneration.
We next sought to investigate whether mammals presented
similarities with the adult zebrafish in terms of miR-99/100 and/
or Let-7a/c expression and functionality. Therefore, we first eval-
uatedmiR-99/100, Let-7a/c, and FNTb/SMARCA5 expression at
different stages during murine and human cardiomyocyte differ-
entiation and heart development. qRT-PCR and immunofluores-
cence analyses demonstrated the progressive upregulation of
miR-99/100 and Let-7a/c as heart development and maturation
proceeds (Figures 4A–4G and S4A–S4C). Interestingly, neonatal
murine cardiomyocytes, which although still proliferative quickly
lose those capabilities after birth, presented significantly higher
levels of miR expression than embryonic cardiomyocytes, and
no Fntb neither Smarca5 mRNAs could be detected (Figures
4C and 4D). Thus, suggesting that higher levels of miR-99/100
and Let-7a/c are required for cardiomyocyte maturation in line
with a recent report by Coppola et al. (2014) or, alternatively,
that distinct mechanisms control neonatal and adult cardiomyo-
cyte proliferation. By employing human embryonic stem cell-
derived cardiomyocytes, we were able to partially recapitulate
human cardiomyocyte development in a dish, revealing that
low levels of miR-99/100 and high levels of FNTb/SMARCA5
are necessary at early stages for cardiac specification and are
lost when cardiomyocytes mature (data not shown). Adult mu-
rine and human heart tissue demonstrated extremely high levels
of miR-99/100, a point at which FNTb/SMARCA5 expression
was undetectable (Figures 4A–4G). Interestingly, analyses of
postmortem injured human heart tissue suggested a failure to
upregulate FNTb/SMARCA5 expression, while both proteins
were expressed in the developing embryonic human heart but
absent in the adult (Figure S4D). To further demonstrate that
this was not due to the temporal window analyzed, as adult hu-
man hearts can rarely be obtained from an individual right after
an infarction has occurred, we additionally performed myocar-
dial infarction experiments in adult mice. Our results indicated
that murine hearts are unable to elicit a natural downregulation
of miR-99/100 and Let-7a/c and presented levels comparable
to those observed on sham-operated animals (Figures 4H,
S4E, and S4F). Collectively, these results suggested that adult
(C and D) Immunofluorescence analysis demonstrating high levels of Fntb (C) and Smarca5 (D) alongside markers indicative of proliferation, PCNA (C) and H3P
(D), in dedifferentiating cardiomyocytes (n = 5).
(E and F) Quantitative analysis confirming the significantly higher number of MyHC+ cardiomyocytes coexpressing Fntb/PCNA (E) and Smarca5/H3P (F) in the
regenerating zebrafish heart (n = 5 animals, three different sections per animal). Dashed line, amputation plane; boxed area, magnified field. Arrows indicate cells
of interest. Data are represented as mean ± SEM. *p < 0.05.
See also Figures S2 and S3.
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Figure 3. Heart Regeneration Is Controlled by miR-99/100
(A–C) Following adult zebrafish heart amputation, exogenous intracardiac administration of 0.2 mg miR-99/100 mimics every second day for a total of 14 days led
to defective cardiac regeneration in amputated zebrafish (A, upper row), as determined by reduced BrdU incorporation (A, lower row and C).
(D–F) miR-99/100 antagomiRs exerted the opposite effect in uninjured adult animals, inducing a significant increase in ventricle size (D, upper panels, and E) and
increasing cardiomyocyte proliferation in the absence of heart damage (D, lower panels, and F).
(G–I) Chemical inhibition of fnt activity with tipifarnib upon intraperitoneal injection (final concentration 0.02 mg per animal) every 2 days for 14 days dramatically
reduced heart regeneration in amputated zebrafish as compared with control animals administered with the solvent DMSO control (G and H) and reducing
cardiomyocyte proliferation as assessed by BrdU incorporation (G, lower panels, and I). Dashed line, amputation plane; boxed area, magnified detail. Data are
represented as mean ± SEM. *p < 0.05; n = 6 animals. Three different sections per animal were used for quantitative analyses.
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mammals, in contrast to zebrafish, might fail to regenerate their
heart due to a failure in downregulatingmiR-99/100 and Let-7a/c
and, inversely, upregulate the miR-99/100 targets, FNTb/
SMARCA5, after injury.
Experimental Manipulation of Conserved Regenerative
Pathways Allows Mammalian Cardiomyocyte
Proliferation by Cell Dedifferentiation
Adult zebrafish heart regeneration occurs by the spontaneous
dedifferentiation of resident cardiomyocytes as a response to
injury. Recently, dedifferentiation of somatic cells to a progeni-
tor-like state with proliferative and redifferentiation potential
has been described to occur as a consequence to injury in a
number of different mammalian organs, including the gut and
pancreas (Schwitalla et al., 2013; Zaret, 2008; Ziv et al., 2013),
as an attempt to maintain tissue homeostasis. Neonatal murine
heart regeneration by enhanced cardiomyocyte proliferation
has been reported (Porrello et al., 2011), yet whether de novo
proliferative cardiomyocytes were generated by dedifferentia-
tion as opposed to boosting the inherent proliferative capacity
of neonatal murine cardiomyocytes remains unknown. More
interestingly, recent reports indicate that neonatal heart regener-
ation is accomplished by neovascularization and not necessarily
cardiomyocyte dedifferentiation (Andersen et al., 2014). Regard-
less the case, cell dedifferentiation and repair do not naturally
occur in the adult mammalian heart upon injury to any significant
extent (Senyo et al., 2012). Therefore, we next wondered
whether experimental downregulation of miR-99/100 and/or
let-7a/c in vitro and ex vivo or, inversely, experimental upregula-
tion of SMARCA5 and FNTb, in mammalian cardiomyocytes,
could lead to dedifferentiation in an analogous manner to that
observed during zebrafish heart regeneration. Seven days after
miR-99/100 and/or let-7a/c silencing by anti-miR delivery (Fig-
ures S5A and S5B), significant upregulation of SMARCA5 and
FNTbwas observed in cultured adult primary murine cardiomyo-
cytes compared with the respective scrambled and mock vector
controls (Figures 5A–5C). Importantly, an increased amount of
GATA4, a marker associated with dedifferentiated cardiomyo-
cytes (Kikuchi et al., 2010), was also observed (Figures 5A, 5B,
and 5D). Accompanying dedifferentiation we observed PCNA
re-expression (Figures 5A, 5B, and 5D) and increased formation
of human cardiomyocyte beating colonies (Movies S1, S2, and
S3), suggesting the acquisition of a proliferative phenotype
similar to that observed during zebrafish regeneration (Jopling
et al., 2010; Kikuchi et al., 2010). In support of cardiomyocyte
specificity, microRNA downregulation did not affect proliferation
nor FNTb/SMARCA5 expression in human fibroblasts or
vascular cells (Figures S5C and S5D). To provide further in-
sights into the gene expression changes occurring during
mammalian cardiomyocyte dedifferentiation, neonatal cardio-
myocytes were transduced with the different anti-miRs and their
respective negative control. Seven days after infection, GFP+
cells were sorted out and analyzed by RNA-seq (Figures S5E
and S5F and Table S2). Transcriptomic analysis revealed differ-
ences in genes involved in epigenetic remodeling and demethy-
lation, cardiac development, proliferation, and unexpectedly,
metabolic pathways (Figures 5E–5H and S5G). Furthermore,
and in an effort to offer a more comprehensive view of transcrip-
tomic changes, we performed semiquantitative mass spectrom-
etry on regenerating zebrafish hearts, neonatal mouse hearts,
and ex vivo adult myocardial mouse tissue treated with the
anti-miRs to find out changes at the translational level (Figure 5I
and Table S3). A cross-species comparison of the differentially
regulated proteins confirmed the transcriptomic findings and
identified dozens of metabolic and mitochondrial processes as
key actors, while also highlighting changes in the cytoskeleton
and chromatin state in the regeneration-permissive state (Fig-
ure S5H and Table S3). Given the newfound importance of meta-
bolic processes and considering that changes in metabolism
have been ascribed to the dedifferentiation of somatic cells to
induced pluripotent stem cells (iPSCs) (Panopoulos et al.,
2012; Shyh-Chang et al., 2013b) and regeneration (Shyh-Chang
et al., 2013a), we decided to investigate whether similar pro-
cesses underlined anti-miR-elicited cardiomyocyte dediffer-
entiation. First, since Lin28 expression has been linked to an
increase in oxidative phosphorylation, regeneration, and Let-
7a/c biogenesis, we evaluated Lin28 expression in primary adult
murine cardiomyocytes subjected to anti-miR treatments. qPCR
analyses demonstrated lack of Lin28 mRNA in any of the
analyzed conditions (data not shown), in line with previous re-
ports demonstrating that Lin28-mediated responses were
context specific and did not result in heart regeneration (Shyh-
Chang et al., 2013a). Along the same line, seahorse analysis indi-
cated an increase in the ratio between glycolysis and oxidative
phosphorylation in line with the metabolic changes observed
during dedifferentiation to iPSCs (Figure S6A). Interestingly,
mitochondrial fusion has been recently described to accompany
cardiomyocyte differentiation (Kasahara et al., 2013). In line with
these observations, we observed a highly fused and organized
mitochondrial network in differentiated primary cardiomyocytes,
whereas anti-miR delivery resulted in mitochondrial network
fragmentation indicating cardiomyocyte dedifferentiation (Fig-
ure S6B). We then decided to employ a different experimental
setting closer to in vivo conditions—i.e., ex vivo myocardial tis-
sue cultures of adult murine hearts—to further understand the
whole extend of the dedifferentiation process. Ex vivo tissue
has the advantage of providing amicroenvironment more closely
resembling that present in the heart. Lentiviral-mediated
silencing of miR-99/100 and/or miR-Let-7a/c to hypoxic and
nonhypoxic murine heart organotypic slices (Brandenburger
et al., 2012) (Figure 6A) resulted in sarcomeric disassembly (Fig-
ure 6B) and the downregulation of Connexin 43 (Cx43) and
MyHC (Figures 6C, 6D, and S6C). Accompanying cardiomyocyte
dedifferentiation, H3 phosphorylation, and re-expression of
GATA4 were also observed (Figures 6C, 6D, and S6C). More-
over, necrosis, which is readily observed in control organotypic
slices subjected to hypoxia, was reduced after anti-miR delivery
(Figure 6E). Taken together, our results demonstrate that exper-
imental downregulation of miR-99/100 and Let-7a/c triggers the
dedifferentiation of mammalian cardiomyocytes to a proliferative
state able to reduce necrosis ex vivo.
Considering that microRNAs are pleiotropic molecules
controlling expression of multiple downstream target genes,
we next sought to investigate whether FNTb/SMARCA5 upre-
gulation alone could suffice for the induction of cardiomyocyte
dedifferentiation and proliferation in mammalian cardiomyo-
cytes. We speculated that if the main role of miR-99/100
during heart regeneration was to upregulate endogenous
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Figure 4. The miR-99/100-Dependent Heart Regeneration Pathway Is Developmentally Conserved in Mammals but Fails to Activate upon
Injury
(A and B) qRT-PCR analysis showing the expression of miR-99/100 and Let-7a/c (A), their protein targets and key cardiac transcription factors (B) during human
cardiac differentiation (n = 5). Human embryonic stem cell line H1 (H1 ESC). LV, left ventricle; RV, right ventricle.
(legend continued on next page)
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FNTb/SMARCA5 expression, overexpression of these proteins
might allow bypassing the requirement for microRNA downregu-
lation altogether. Indeed, overexpression of either protein in pri-
mary murine cardiomyocytes cultured in vitro resulted in the
appearance of dedifferentiated phenotypes, including GATA4
expression and ultimately, cell proliferation (Figure 6F). To further
demonstrate specificity, we devised an experimental design
conceptually similar to traditional rescue experiments. In con-
trast to our overexpression experiments, should FNTb and
SMARCA5 be the major players controlling mammalian cardio-
myocyte dedifferentiation and heart regeneration downstream
of miR-99/100, concomitant siRNA-mediated knockdown of
Fntb and Smarca5 alongside delivery of anti-miR-99/100 should
result in impaired cardiomyocyte dedifferentiation and prolifera-
tive potential. As expected, downregulation of the downstream
effectors Fntb and Smarca5 in anti-miR-99/100-treated cells
significantly abrogated mammalian cardiomyocyte dedifferenti-
ation and proliferation (Figure 6G). Finally, we wondered whether
miR-99/100 and let-7 levels, and inversely FNTb and SMARCA5
levels, correlated not only with cardiomyocyte dedifferentiation
but also reciprocally with cardiomyocyte specification. In line
with recent findings (Coppola et al., 2014) reporting a positive
effect of the miR-99/let-7 cluster during embryonic stem cell-
cardiomyocyte differentiation by enhancing mesoderm specifi-
cation, our results further demonstrated that expression of
miR-99/100 and let-7 mimics, or inversely knockdown of FNTb
and SMARCA5, resulted in the maturation of embryonic stem
cell-derived human cardiomyocytes, Interestingly, we observed
a significant upregulation of genes typically associated to adult
mature cardiomyocytes including CX43 andMYL7 (Figure S6D).
Together, these results highlight FNTb and SMARCA5 as critical
targets downstream of miR-99/100 for controlling mammalian
cardiomyocyte dedifferentiation and inversely maturation.
Induction of Cardiomyocyte Dedifferentiation
Facilitates Mammalian Heart Regeneration In Vivo
Finally, we decided to test the in vivo regenerative potential of
anti-miRs delivery in a murine model of MI. Following left anterior
descending (LAD) artery ligation, we first focused on the use of
lentiviral vectors encoding anti-miR-99/100 and anti-Let-7a/c
and the respective mock controls. Intracardial delivery of lentivi-
ruses resulted in significantly improved functional parameters,
including ejection fraction (EF) and fraction shortening (FS) as
compared with nontreated animals (Figure S7A). Indeed, the
values achieved 15 days after treatment did not significantly
differ from those obtained in sham-operated animals. To eval-
uate the potential therapeutic use of anti-miR-99/100 and anti-
Let-7a/c, we next decided to use adeno-associated viruses
serotype 2/9 (AAV2/9) presenting cardiac tropism. AAVs encod-
ing for anti-miR-99/100 and anti-Let-7a/c, or the respective
scrambled controls, were administered by intracardiac injection
in the periphery of the infarcted area. Importantly, functional
heart parameters, as determined by echocardiography, in-
cluding FS, EF, and ventricular wall thickness, significantly
improved in the treated group after 14 and 90 days, as compared
with scrambled controls, to levels closer to those observed in
sham-operated animals but significantly different (Figures 7A
and S7B–S7D). In addition, a significant reduction in fibrotic
scarring as well as in infarct size was observed when treated
injured animals were compared with scrambled MI controls (Fig-
ures 7B, 7C, S7E, and S7F). To determine whether cardiomyo-
cyte dedifferentation and proliferation were taking place, we
performed histological analyses. Our results revealed increased
numbers of cardiomyocytes positive for the miR-99/100 target
genes FNTb and SMARCA5 18 days after injury in anti-miRs-
treated animals (Figures 7D and 7E). Additionally, since knock-
down of FNTb and SMARCA5 facilitated cardiomyocyte matura-
tion, we wondered whether functional improvement could be
due to the specification of resident cardiac precursors. Interest-
ingly, re-expression of GATA4 and PCNA (Figures 7F, 7G, S7G,
and S7H) alongside increased H3 phosphorylation and BrdU
incorporation (Figures 7H, 7I, S7I, and S7J) demonstrated
increased DNA synthesis, suggesting a process of cardiomyo-
cyte dedifferentiation. However, whereas we fail to observe a
substantial population of GATA4+ or PCNA+ cells in scram-
bled-treated or in sham-operated animals, we cannot totally
rule out a contribution from cardiac precursors in this system.
To rule out the possibility that DNA synthesis was occurring inde-
pendently of cell division, we next investigated the expression of
aurora B kinase (ARK-2) and anillin, both indicative of cytoki-
nesis. ARK-2 and anillin expression were readily observed in re-
generating murine hearts (Figures 7J and S7K). In conclusion,
our data demonstrate that failure to naturally downregulate
miR-99/100 and Let-7a/c and subsequent upregulation of their
target genes FNTb and SMARCA5 as a response to heart injury
acts as a major roadblock preventing adult mammalian heart
regeneration. More interestingly, barriers to mammalian heart
regeneration could be experimentally overcome by anti-miR
administration.
DISCUSSION
Despite the fact that yet unknown mechanisms prevent adult
mammals to naturally mount a robust and efficient regenerative
response upon injury (Senyo et al., 2012), our results and those
from others indicate that heart regeneration can be activated in
mammals under certain circumstances (Porrello et al., 2011,
2013; Senyo et al., 2012). Porrello et al. first demonstrated that
an efficient regenerative response occurs in the neonatal murine
heart during the days immediately after birth. This regenerative
(C and D) qRT-PCR analysis showing the expression of miR-99/100 and Let-7a/c (C), their protein targets and key cardiac transcription factors (D) during mouse
development and adult stages (n = 5). mESCs, mouse embryonic stem cells.
(E–G) FISH/immunofluorescence (E and F) and quantitative analysis (G) demonstrating low levels of miR-99/100 and high levels of FNTb and SMARCA5 in E11
murine embryonic hearts as opposed to adult hearts, which showed high levels of miR-99/100 and almost undetectable expression of FNTb and SMARCA5.
(H) FISH/immunofluorescence in adult mouse heart before (upper panels) and after MI (lower panels) highlighted a failure to downregulatemiR-99/100 upon injury
in the murine heart. Data are represented asmean ± SEM. *p < 0.05. (E and F) n = 6 animals; (H) n = 5 animals. In all cases, three different sections per animal were
used for quantitative analyses (G).
See also Figure S4.
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Figure 5. Forced Downregulation of miR-99/100 and Let-7a/c Suffices to Promote Dedifferentiation and Proliferation of Adult Murine Cardi-
omyocytes in Culture
(A) Representative pictures showing that pmiRZip control vector-transduced adult murine cardiomyocytes spontaneously disorganized sarcomeric structures
in vitro but did not dedifferentiate to express FNTb, SMARCA5, GATA4, or the proliferative marker, PCNA.
(legend continued on next page)
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response is completely absent from day 8 onward and in adult
animals. Interestingly, neonatal murine cardiomyocytes differ
from adult cardiomyocytes in that they are able to naturally
proliferate. Therefore, it remains unclear whether neonatal mu-
rine heart regeneration is due to enhanced cardiomyocyte prolif-
eration or to a regenerative response mounted de novo. Most
strikingly, neonatal murine heart regeneration has been recently
ascribed to neoangiogenesis as opposed to amajor contribution
due to newly generatedmyocardial mass (Andersen et al., 2014).
Regardless of the precise mechanisms, these observations
collectively suggest that developmental mechanisms are still
present in the neonatal murine heart and that they might
contribute to tissue repair by promoting cardiomyocyte prolifer-
ation. Indeed, our previous work identified microRNAs boosting
cardiomyocyte proliferation in neonatal murine cardiomyocytes
that sufficed for the partial healing of the mammalian heart (Eula-
lio et al., 2012), albeit the mechanisms at work remain obscure.
In contrast to neonate murine models, the adult heart is
largely comprised of postmitotic cardiomyocytes. Indeed, natu-
ral regeneration is preceded by cardiomyocyte dedifferentiation
and proliferation in organisms able to regenerate their adult heart
(Jopling et al., 2010; Kikuchi et al., 2010; Witman et al., 2011).
These dedifferentiated cardiomyocytes are able to re-enter the
cell cycle and fully repair the injured adult heart as a response
to injury (Jopling et al., 2010; Raya et al., 2003; Wang et al.,
2011). Interestingly, similar proregenerative phenomena, based
on cell dedifferentiation, have been recently described to under-
lie mammalian tissue repair and homeostasis as a response to
injury in the pancreas and intestine (Schwitalla et al., 2013; Zaret,
2008). However, mammalian hearts do not regenerate, nor do
adult mammalian cardiomyocytes naturally dedifferentiate to a
proliferative state upon injury (Jopling et al., 2011). Here we
sought to identify the molecular mechanisms regulating cardio-
myocyte dedifferentiation in the zebrafish heart and speculated
that, if conserved, they might provide a platform for the develop-
ment of in vivo regenerative strategies for the healing of the
mammalian heart.
By systematic screening of molecules differentially regulated
during zebrafish heart regeneration, we report on the identifica-
tion of the molecular effectors controlling zebrafish heart regen-
eration and their application for the induction of regeneration in
the injured adult mammalian heart. miR-99/100 expression
was high in the uninjured zebrafish heart and underwent rapid
downregulation upon injury. Concomitant to miR-99/100 down-
regulation, expression of multiple downstream target genes was
observed. Among all different target genes, we identified fntb
and smarca5 as critical regulators of zebrafish heart develop-
ment and regeneration. Interestingly, similar patterns of expres-
sion were observed during mammalian heart development.
Mature nonproliferative cardiomyocytes in the zebrafish, human,
and mouse demonstrated maximal levels of microRNA expres-
sion accompanied by absent GATA4, FNTb, and SMARCA5
expression. Noticeably, whereas the adult zebrafish efficiently
downregulated miR-99/100 expression to undergo regeneration
as a response to injury, mammals seemingly failed to endoge-
nously activate such mechanisms in spite of being present and
playing the exact same role. Experimental downregulation of
miR99-100 in human, neonatal, and adult murine cardiomyo-
cytes resulted in the acquisition of a dedifferentiated phenotype,
as best exemplified by GATA4 re-expression, expression of
proliferative markers, and sarcomeric disassembly. Noticeably,
dedifferentiation seemed limited to mononucleated cardiomyo-
cyte populations, raising the interesting question of whether
mononucleated cardiomyocytes are more responsive to the
activation of this signaling pathway or alternatively that poly-
nucleated/polyploidy cardiomyocytes can somehow revert to a
mononucleated state. Genetic lineage tracing approaches might
be able shed some light on this issue in the future.
Among all different target genes regulated by miR-99/100, we
unveiled two major proteins, FNTb and SMARCA5, as critical
regulators of mammalian cardiomyocyte dedifferentiation and
regeneration. Overexpression of either protein resulted in mam-
malian cardiomyocyte dedifferentiation and induction of prolifer-
ation even when miR-99/100 expression was not experimentally
downregulated, a phenomenon enhanced when both proteins
were simultaneously overexpressed. Conversely, downregu-
lation of miR-99/100 by anti-miR delivery in the presence of
siRNAs targeting Fntb and Smarca5 abrogated mammalian car-
diomyocyte dedifferentiation and proliferation. Instead, miR-99/
100 and let7 overexpression, or inversely Fntb and Smarca5
knockdown, facilitated cardiomyocyte maturation.
Interestingly, metabolic reprogramming as a response to
Lin28 upregulation, a regulator of let-7 biogenesis, has been
shown to elicit a regenerative response in mammalian organs
other than the heart (Shyh-Chang et al., 2013a). Thus, adult
mammalian heart regeneration might be subjected to different
mechanisms in a context-dependentmanner. Indeed, our results
indicate that treatment with Let-7a/c alone did not suffice for
mounting an efficient regenerative response, as observed by
incomplete sarcomeric disassembly, whereas blocking miR-
99/100 efficiently led to sarcomeric disassembly and GATA4
expression, indicating cell dedifferentiation. More robust results
in inducing cardiomyocyte dedifferentiation and adult heart
regeneration were obtained when both miR99-100 and Let7c
(B) Upon lentiviral transduction with anti-miR-99/100, adult cardiomyocytes dedifferentiate and express PCNA, GATA4, and both miR targets.
(C and D) Quantitative analysis of FNTb and SMARCA5 (C) or GATA4 and PCNA (D)-positive adult cardiomyocytes after different anti-miR treatments.
(E and F) Most relevant upregulated (E) and downregulated (F) functional gene ontology processes observed during in vitro cardiomyocyte dedifferentiation with
anti-miRs.
(G and H) Clusters of genes indicating themost relevant upregulated (G) and downregulated (H) groups involved in cardiomyocyte dedifferentiation. As expected,
epigenetic remodeling and developmental processes appeared as highly represented.
(I) Comparative proteomic analysis of the heart during regenerative stages. Adult regenerating zebrafish hearts (uninjured, 3 dpa, 7 dpa), neonatal regeneration-
permissive mouse hearts (P0, P7, adult), and anti-miR treated adult myocardial mouse tissue (control, anti-miR-99/100, anti-Let-7a/c, anti-miR-99/100+anti-Let-
7a/c) were collected and processed for semiquantitative mass spectrometry to determine their translational profiles. The Venn diagram depicts differentially
regulated protein candidates for each stage and species after a cross-comparison to find common protein effectors involved in the maintenance or transition to a
regeneration-permissive state. Data are represented as mean ± SEM. *p < 0.05; n = 3 independent experiments.
See also Figure S5 and Tables S2 and S3.
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Figure 6. Myocardial Tissue Can Be Induced to a Partially Dedifferentiated Proliferative State by Anti-miR Treatment
(A) Diagram describing organotypic culture experiments: ventricles were obtained from wild-type mice, cut into slices, and put in culture conditions. At 24 hr, they
were transducedwith the anti-miR constructs and evaluated by immunohistochemistry (IHC) analyses for cardiomyocyte proliferation/dedifferentiation after 7 days.
(legend continued on next page)
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were inhibited by their respective anti-miRs, therefore suggest-
ing that sarcomeric disassembly represents a barrier to the
dedifferentiation effect of Let-7. Ultimately, modulation of the
identified regenerative machinery in adult murine models of MI
resulted in the significant improvement of heart functionality.
Induced mammalian heart regeneration seems to be accom-
plished by a process of cardiomyocyte dedifferentiation resem-
bling what naturally occurs in the zebrafish as a response to
injury (Jopling et al., 2011; Laflamme and Murry, 2011).
Our results represent a proof of concept on how the identifica-
tion of conserved regenerative effectors in animal models natu-
rally able regenerate their tissues may serve for the development
of strategies toward inducing in vivo reprogramming to a dedif-
ferentiated state in mammals. Altogether, in vivo activation of
conserved cardiac regenerative mechanisms may help to cir-
cumvent concerns associated with heart cell transplantation as
well as those associated with other reprogramming technologies
(Abad et al., 2013; Aguirre et al., 2013; Qian et al., 2012; Song
et al., 2012; Vierbuchen and Wernig, 2011), adding an additional
tool to the clinical armamentarium of regenerative medicine to-
ward the treatment of human heart disease.
EXPERIMENTAL PROCEDURES
Animals
All protocols were previously approved and performed under institutional
guidelines. WT (AB) and cmlc2:GFP zebrafish were maintained at 28.5C
following standard methods. CD1 and C57BL mice were housed and main-
tained at the Salk Institute and ICGEB animal facilities. Mouse care and treat-
ments were conducted in conformity with institutional guidelines in compliance
with national and international laws and policies (EEC Council Directive 86/609,
OJL 358, 12 December, 1987) (ICGEB). Zebrafish work was conducted in con-
formity with Salk Institute IACUC and AAALAC guidelines.
Zebrafish Heart Amputation
Adult fish were anaesthetized in 0.4% Tricaine and secured, ventral side up-
permost, in a slotted sponge. Watchmaker forceps were used to remove the
surface scales and penetrate the skin, muscle, and pericardial sac. Once
exposed, the ventricle was gently pulled at the apex and cut with iridectomy
scissors. After surgery, fish were immediately returned to system water.
Myocardial Infarction
Myocardial infarction was induced in CD1 mice (8–12 weeks old) by perma-
nent LAD coronary artery ligation as described elsewhere (Eulalio et al.,
2012). Briefly, mice were anesthetized with an injection of ketamine and xyla-
zine and were intubated and placed on a rodent ventilator. Body temperature
was maintained at 37C. After removing the pericardium, a descending
branch of the LAD coronary artery was visualized with a stereomicroscope
and occluded with a nylon suture. Ligation was confirmed by the whitening
of a region of the left ventricle. Recombinant AAV vectors or lentiviruses, at
a dose of 1011 viral genome particles per animal, were injected immediately
after LAD ligation into the myocardium bordering the infarct zone (single injec-
tion), using an insulin syringe with incorporated 30-gauge needle. Several
groups of animals were studied: receiving control lentiviruses (coding for an
empty vector) or anti-miRs-99/100 and Let-7a/c coding lentiviruses or
AAV9 controls (empty vector and scrambled shRNA-Luc) or AAV9-anti-miR-
99/100 + AAV9-anti-Let-7a/c. Sham-operated groups and noninfarcted but
injected groups were additionally included as control groups for AAV and
lentivirus injected groups, respectively. The chest was closed, and the ani-
mals moved to a prone position until the occurrence of spontaneous breath-
ing. Echocardiography analysis was performed at day 15 (lentiviral injections)
or at days 14 and 90 (AAV-injected animals) after surgery, and hearts were
collected at 18 and 90 days after infarction. All groups were analyzed in a
blinded and randomized manner by a minimum of two experimenters.
Lentiviral and AAV Constructs
Anti-miR constructs, miRZip-99/100 andmiRZip-let7 (SBI), were used accord-
ing to the manufacturer’s instructions. As respective controls, the anti-miRs
were removed from the parent vector by digesting with BamH1 and EcoR1
and were end filled and religated. Lentiviruses were packaged by transfecting
in 293T cells followed by spinfection in the respective mouse or human ES-
derived cardiomyocytes. AAVs were generated as described before (Eulalio
et al., 2012). Briefly, the anti-miR constructs contained in the miRZip vectors
were excised and ligated into pZacf-U6-luc-ZsGreen. Serotype 9 AAVs were
packaged by transfection of 293T cells with the appropriate plasmids.
Organotypic Heart Slice Culture
Mice ventricles (C57BL) were washed in cold Modified Tyrode’s Solution,
embedded in 4% low melting point agarose, and immediately cut into
300 mm slices using a vibratome (Leica). Heart slices were then maintained
in complete Iscove’s modified Dulbecco’s medium 5%, 1% Pent/Strep in
12-well plates at the medium-air interface using 0.4 mm membrane transwells
(Corning) at 37C in a 5% CO2 incubator. For experimental hypoxia-like con-
ditions, slices were kept in a hypoxia chamber incubator for 4 hr at 37C,
5% O2. Lentiviral transduction was performed by immersion of the slices in vi-
rus-containing medium for 24 hr.
Confocal Microscopy
Samples were imaged using a Zeiss L710 confocal microscope. For every
sample, at least two different fields were examined at two different magnifica-
tions (using a 203 objective and a 633 oil-immersion objective). Z stacks were
obtained for further analysis and 3D reconstruction. For intensity comparison
purposes, images were taken under the exact same conditions (pinhole size,
laser intensity, etc.). Automatic cell counting was performed with ImageJ
and Metamorph software.
Statistical Analysis
Results are expressed as mean ± SEM. Results are representative of at least
three independent experiments except when otherwise indicated. Statistical
analysis was carried out using Prism Software (GraphPad). For statistical com-
parison of two groups, unpaired, two-tailed Student’s t test was used; for the
(B) Representative pictures showing that sarcomeric disorganization was readily observed by electronmicroscopy after induced dedifferentiation in adult cardiac
tissue.
(C) Quantitative analyses of normoxic organotypic cultures demonstrating significant increases in FNTb and SMARCA5, enhanced numbers of dedifferentiated
cardiomyocytes—determined by Cx43 and GATA4 expression—and significantly increased numbers of proliferating cells, upon anti-miR treatment.
(D) Quantitative evaluations of hypoxic organotypic cultures demonstrating cardiomyocyte dedifferentiation upon anti-miR treatment as indicated by GATA4 re-
expression, a reduced number of Cx43+ cells, and increased H3P.
(E) Histomorphometric evaluation of the damaged myocardium in normoxic and hypoxic conditions after Masson’s trichrome staining.
(F) Lentiviral overexpression of Fntb, Smarca5, or both is sufficient to impose a dedifferentiated profile in neonatal murine cardiomyocytes.
(G) In primary neonatal murine cardiomyocytes, knockdown of miR 99/100 and Let-7a/c is insufficient to promote a dedifferentiated state in the absence of Fntb/
Smarca5 (knocked down with siRNAs), suggesting that these two proteins are mostly responsible for the effects of the miRs. The dashed lines represent the
baseline values in the untreated condition (absolute values being 8% H3P+ and 2.5% GATA4+ cells). Data are represented as mean ± SEM. *p < 0.05; n = 4
independent experiments/condition. Three sections/experiment/condition were used for quantitative analyses.
See also Figure S6.
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Figure 7. miR-99/100 and Let-7 Silencing Is Sufficient to Induce Heart Regeneration in a Murine Model of MI
(A) AAV2/9 (a serotype showing cardiomyocyte specificity) GFP-mediated anti-miR-99/100 and anti-Let-7 in vivo delivery in a mouse model of MI resulted in the
significant improvement of FS (left panel), EF (middle panel), and left ventricular anterior wall thickness (LVAW, right panel) at 14 and 90 dpi as compared with
AAV2/9-GFP scrambled injected animals.
(legend continued on next page)
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comparison of three or more groups, one-way ANOVA followed by Tukey’s
post hoc test was used. A value of p < 0.05 was considered significant.
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